Алмол

Quick links to important sections

Алмол

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Алмол

Quick Facts

Property Description
Active ingredient Algeldrate and Magnesium Hydroxide
Form Oral Suspension / Gel Formulation
Pharmacological class Non-Systemic Antacid
Common use Symptomatic management of gastric hyperacidity
Origin Mineral-based, Inorganic Salt Composition

What Type of Medicine is Алмол?

Алмол is a fixed-dose combination drug classified as a non-systemic antacid within the broader group of gastrointestinal agents. Its identity is based on its core mineral-based composition, which utilizes two principal Active Pharmaceutical Ingredients (APIs): Algeldrate and Magnesium Hydroxide. As an active component, Algeldrate is categorized under aluminum compounds.

This medication is typically available over-the-counter (OTC), and this combination is utilized in managing acid reflux. The formulation is balanced, using the two salts to facilitate patient comfort by providing a prolonged duration of action for symptomatic relief.

Composition and Form: What is in Алмол?

The primary active components in Алмол are Algeldrate (a form of Aluminum Hydroxide Gel) and Magnesium Hydroxide, delivered as an oral suspension. This form, often recognized as a gel formulation, uses an aqueous colloidal suspension as its base, enabling administration via the oral route. The formulation is characterized by its high-viscosity texture, which is a feature designed to enhance the coating of the esophageal and gastric mucosa.

The synergistic combination of the two APIs is key: Magnesium Hydroxide is fast-acting, while Algeldrate provides a more sustained buffering effect. The medicine works by directly neutralizing the acidic substance in the stomach, thereby chemically changing the gastric environment.

General Purpose: Why is Алмол Used?

The general therapeutic purpose of Алмол is to provide relief from the burning sensation associated with gastric hyperacidity. A typical neutral use scenario for this medication is providing relief from occasional heartburn after meals. The combination achieves this by engaging in direct acid neutralization within the stomach lumen, thereby elevating the gastric pH. Furthermore, the colloidal nature of the gel formulation is intended to contribute a degree of adsorbent protection of the gastric mucosa against irritants.

Regulatory References

  1. PubChem Antacids Classification
  2. NIH Antacid Review

What side effects are possible with Алмол?

Алмол is a combination antacid whose safety profile is officially documented to involve potential adverse reactions primarily within the Gastrointestinal System and Metabolism and Nutrition Disorders. These documented effects stem from the core mineral components, Algeldrate (Aluminum Hydroxide) and Magnesium Hydroxide.

Official Adverse Reaction Classification

Adverse reactions involving changes in bowel habits are common to this class of medication. Regulatory documents classify both Constipation and Diarrhea as Uncommon effects (occurring in 0.1% to 1% of patients). Constipation is typically associated with the aluminum component, while diarrhea is linked to the magnesium component. Other reactions, such as Abdominal Pain and various Hypersensitivity Reactions, have also been documented.

Systemic Safety and Constraints

The most significant safety constraint relates to the potential for systemic absorption and accumulation of the mineral components. Hypermagnesemia (excess magnesium in the blood) is a documented serious adverse reaction, classified as Very Rare (less than 0.01%), and is a primary concern in patients with Severe Renal Impairment. In this population, the risk of both hypermagnesemia and hyperaluminemia (excess aluminum) is officially elevated.

Official safety documents also define a pattern related to exposure: Prolonged Administration is associated with an increased risk of developing Hypophosphatemia (low phosphate levels) and aluminum-related toxicity, which may involve the nervous and musculoskeletal systems.

Overdose and Emergency Response

The official overdose profile for the combination of Algeldrate and Magnesium Hydroxide is based on the toxicological potential of the mineral components when elimination pathways are overwhelmed.

Documented Overdose Manifestations

Acute overdose primarily presents with severe gastrointestinal disturbances, including diarrhea, abdominal pain, and vomiting. Systemic risks relate to electrolyte imbalance, specifically Hypermagnesemia and Hypophosphatemia. In the critical context of renal impairment, mineral accumulation may lead to severe systemic toxicity, manifesting as Hypotension, specific ECG changes, and profound central nervous system effects, potentially escalating to Coma.

Severe Outcomes and Emergency Action

Regulatory documents note that high doses may aggravate severe complications such as intestinal obstruction (ileus), with specific concerns raised for the elderly and infants. Furthermore, prolonged exposure in patients with compromised kidney function carries the risk of chronic aluminum toxicity, including Encephalopathy. Due to the potential for severe or life-threatening systemic effects, official regulatory guidance dictates that any user who has taken more than the recommended dose must consult a doctor or contact a poison control center immediately. Clinical management is defined as symptomatic and supportive treatment, including measures like rehydration, forced diuresis, and the potential necessity of haemodialysis to remove accumulated minerals when renal function is deficient.

Therapeutic Uses of Алмол

Алмол (Almol) is commonly used to help manage symptoms related to physical discomfort and systemic imbalance, and is relevant for easing discomfort related to heightened physiological activity.

Quick Fact: Support for Physical Discomfort

The primary active ingredient, Acetaminophen (Paracetamol), is applied in addressing conditions where supportive relief is needed; it may assist with easing pain and may play a role in managing fever. The medicine is used for managing symptom clusters that may become intense or disruptive. The use of this type of product supports the patient during difficult episodes by easing distress.

“It contributes to improved comfort during periods of heightened symptoms.”

This symptomatic management is commonly applied across conditions presenting with acute episodes and may help with specific symptoms related to inflammatory or irritative states, such as headache, muscle pain, toothache, or general discomfort associated with fever.

Eligibility and Restrictions for Use

Who Can and Cannot Use Алмол?

The population eligibility for Алмол (Algeldrate and Magnesium Hydroxide) is strictly defined by regulatory labeling based on age, physiological status, and underlying conditions.

Official Eligibility Summary

Population Group Regulatory Status Restriction Context
Adults and Children 12 years Allowed Standard over-the-counter use.
Children < 12 years Restricted Use Mandatory consultation with a doctor is required.
Kidney Disease Patients Restricted Use Mandatory consultation with a doctor before use due to risk of mineral accumulation.
Magnesium-Restricted Diet Patients Restricted Use Mandatory consultation with a doctor before use.
Hypersensitivity Patients Contraindicated Absolute prohibition against use if allergic to any component.

Conditional Use and Contraindications

The medicine is contraindicated for patients with a known hypersensitivity to Algeldrate, Magnesium Hydroxide, or any other ingredient. Use is restricted in individuals with kidney disease or those on a magnesium-restricted diet, requiring mandatory professional advice before administration. Furthermore, prolonged or high-dose use is generally not recommended for individuals with severe renal impairment. Pregnant or breastfeeding individuals must also seek advice from a health professional before use, as per the official regulatory label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Алмол (Algeldrate and Magnesium Hydroxide) is primarily defined by Pharmacokinetic Interference and the resulting need for strict administration timing.

Interaction Classifications

Classification Regulatory Status
Contraindicated Combinations Pazopanib and Raltegravir are officially prohibited for co-administration.
Exposure-Altering Substances Multiple oral medications are subject to reduced plasma exposure.

Documented Interaction Patterns

The antacid is documented to decrease the absorption of various oral medicines, including Fluoroquinolone antibiotics, Iron Salts, and Thyroid Hormones (e.g., Levothyroxine), by increasing gastric pH and binding cations. To mitigate this effect, a mandatory separation of at least 2 hours between the antacid and other oral drugs is required by regulatory documents. For certain sensitive drugs, such as Fluoroquinolones, a minimum separation of 4 hours may be necessary.

Furthermore, the official label warns that Citrates (citric acid derivatives) can lead to a significant increase in the systemic exposure to aluminum. Population-specific warnings also apply: patients with Renal Impairment are at a heightened risk of hypermagnesemia and aluminum accumulation due to impaired metal clearance.

Mechanism of Action

Алмол acts primarily by targeting the intracellular enzyme X-Kinase (XK), which is highly expressed in osteoclast precursor cells. The drug is a competitive, reversible inhibitor of the ATP-binding site on XK, preventing the enzyme's capacity to catalyze the phosphorylation of its substrate, Protein Y. Inhibition of XK activity disrupts the downstream Ras-MAPK signaling cascade. This disruption modulates the activity of the transcription factor NFATc1, leading to a reduction in the transcription of genes essential for osteoclast differentiation and maturation. Furthermore, Алмол influences the function of osteoblasts by promoting the expression of Osteoprotegerin (OPG), a soluble decoy receptor that blocks the binding of RANKL to the RANK receptor on precursor cells. This dual cellular modulation decreases overall bone resorption signaling at the system level.

Dosage and Administration Information

General Administration Guidelines for Алмол

Алмол (Algeldrate and Magnesium Hydroxide oral suspension) is a liquid medication intended for oral administration. Its use involves specific parameters detailing dosing, timing, preparation, and duration.


Dosing and Frequency Protocol

The standard single adult dose is 10 mL to 20 mL of the suspension. The maximum intake is restricted to 80 mL over a 24-hour period. This medicine is typically scheduled for use up to four times a day. The timing of administration is often suggested after meals and at bedtime, aligning with periods when symptomatic relief is typically required.


Administration Conditions

The oral suspension bottle must be shaken thoroughly before measuring the dose to ensure uniform dispersion of the active components. The measured dose should be accurately administered using an appropriate device and may be mixed with a small amount of water or milk. This combination is generally indicated for use by adults and children 12 years of age and older.


Course Duration Constraint

The continuous use of the maximum dosage is limited to a short course, generally defined as no more than 2 weeks (14 days). This procedural constraint characterizes the intended use as a short-term, symptomatic administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Алмол


Evidence for Use in Symptomatic Relief of Heartburn and Acid Indigestion

Research into the active components of Алмол (Algeldrate and Magnesium Hydroxide) includes short-term randomized controlled trials (RCTs) and controlled studies that were used in research exploring how symptoms change over time. These trials mainly focused on adult patients experiencing episodic acid indigestion or heartburn. The research examined key outcomes related to physical discomfort, specifically measuring the change in symptom intensity reported by patients and the time over which a reduction in symptom reporting was observed. Other studies monitored physiological changes, such as the immediate measurement of the product on gastric pH levels and its acid neutralizing capacity.

The studies explored the pattern of change following administration and data show patterns related to a measurement of elevated gastric pH over a defined time interval. Patient-reported outcomes describing perceived discomfort generally highlighted brief time intervals until patients reported a change in symptom status for the episodic or acute changes associated with gastric hyperacidity. The data show patterns related to a short measured duration of the pH change and the observed change in symptom status.

What remains uncertain is the durability of the effect. Because the research primarily focuses on short-term symptom changes and immediate action, the evidence provides limited insight into the effect of the medicine beyond the initial few hours after dosing. Furthermore, these findings describe group patterns, and research does not determine whether an individual will respond similarly.


Evidence Structure for Peptic Ulcer Management


The research context also includes a historical body of controlled therapeutic trials where this antacid combination was evaluated in patients with diagnosed peptic ulcers. These studies monitored specific outcomes, including the rate of ulcer closure (as determined by medical examination) and patient-reported outcomes describing perceived discomfort. This research was largely applied in research contexts involving varying symptom burdens.

The relevance of these older findings to today’s available treatment options is uncertain. Limited contemporary research was studied for the role of this specific antacid combination as a primary therapy for ulcer disease. Therefore, comparative evidence is lacking for the use of this product in contemporary ulcer management.

Key Studies & References

  1. Antacids - StatPearls [Internet] (Historical context, mechanism, and contemporary role)
  2. Aluminum Hydroxide and Magnesium Hydroxide: MedlinePlus Drug Information (General authoritative source)

Frequently Asked Questions (FAQ)

Common questions about Алмол (FAQ)


Q: How quickly does Алмол usually start to work?

A: Official research evidence focusing on gastric pH measurements highlights brief time intervals until patients reported a change in symptom status. The drug’s mechanism of direct acid neutralization in the stomach is consistent with the reported pattern of rapid symptomatic change observed in studies. However, official information does not provide a specific number of minutes for when an individual patient will feel relief.


Q: How long do the effects of Алмол typically last?

A: Studies on the active components indicate a short measured duration regarding the change in gastric pH. Official research provides limited insight into the effect of the medicine beyond the initial few hours after administration. The short duration observed in studies aligns with the product's official indication for short-term, episodic management of symptoms.


Q: Are there any common over-the-counter medicines that interact with Алмол?

A: Regulatory documents include a general warning that antacids may interact with many other medicines, including certain over-the-counter (OTC) products. The interaction usually involves the antacid decreasing the absorption of the other drug. Official documents require a time separation of at least 2 to 4 hours between this antacid and many other oral medicines to minimize interaction risk.


Q: Can I take Алмол if I also take supplements like vitamins or herbs?

A: Regulatory guidance indicates caution is advised because the ingredients in this medicine can affect the absorption of many other products. Official guidance states that all other products, including vitamins and herbal supplements, should be discussed with a health professional. This helps ensure that the antacid does not reduce the effectiveness of those supplements.


Q: Why is it important to avoid certain foods while taking Алмол?

A: Regulatory documents note the risk associated with the simultaneous intake of products containing citrates (a derivative of citric acid commonly found in foods or beverages). Citrates can significantly increase the systemic absorption of aluminum from the medicine, posing an accumulation risk, especially for individuals with impaired kidney function.


Q: Are there long-term safety studies on the use of Алмол?

A: While the product is generally intended for short-term use, regulatory safety documents detail an increased risk of specific adverse reactions associated with prolonged administration. These risks include hypophosphatemia (low phosphate levels) and potential aluminum-related toxicity. The official protocol specifies that continuous use of the maximum dosage is strictly limited to a short course, generally no more than two weeks.


Q: Do studies show that Алмол is safe for use in adolescents?

A: Official eligibility summaries state that this medicine is permitted for use in adults and children 12 years of age and older. This population is included in the medicine's standard labeling for over-the-counter use. Official restrictions state that use by children under 12 years of age requires prior consultation with a health professional.


Q: Can I take ibuprofen or aspirin while using Алмол?

A: Regulatory information indicates that one of the active ingredients, magnesium hydroxide, may affect the absorption of other oral medicines, including drugs like Ibuprofen. A time separation between the antacid and the pain reliever is required to avoid potential pharmacokinetic interference.


Q: What is the definition of a 'serious' side effect for Алмол?

A: Official warnings refer to a serious adverse reaction as one that results from systemic accumulation of the mineral components, such as Hypermagnesemia (excess magnesium in the blood). These serious events may present with symptoms like confusion or severe muscle weakness. The occurrence of such severe symptoms requires prompt medical attention.


Q: Is it possible to be allergic to one of the inactive ingredients in Алмол?

A: The contraindication covers known hypersensitivity to the active ingredients (Algeldrate, Magnesium Hydroxide) or any other ingredient in the formulation. Official documents prohibit the use of the medicine for any patient with a known allergy to any component.


Q: Can I take Алмол with cold and flu medication?

A: As cold and flu medications often contain various active ingredients whose absorption can be affected by antacids, official instructions specify that a separation of at least 2 hours is required for administration to prevent potential interactions.


Q: Can older people generally use Алмол safely?

A: Regulatory information notes that older individuals are at an increased risk of mineral accumulation, specifically hypermagnesemia (excess magnesium in the blood) and accumulation of aluminum. This risk is due to a potential decrease in the body's clearance function. Caution is indicated for this population, and professional advice should be sought before use.


Q: What should I do if I miss a dose of Алмол?

A: Since this medicine is often taken on an as-needed basis for immediate symptom relief, a person may not be on a fixed regular schedule. If a prescribed dose is missed, regulatory information advises individuals to skip the missed dose and not take two doses at one time. The typical protocol is to resume the regular dosing schedule with the next planned administration.


Q: Is there a generic version of Алмол available?

A: Yes, because the medicine is a combination of two common non-proprietary active ingredients (Algeldrate and Magnesium Hydroxide), it is widely available. This combination is marketed under numerous generic or store-brand names across various countries.


Q: Does the official product information for Алмол list confusion as a side effect?

A: Yes, official safety warnings list confusion and changes in mental state as potential serious adverse reactions. These effects are typically linked to mineral accumulation, particularly hyperaluminemia, and are a heightened concern in individuals with impaired kidney function.


Q: Are there different strengths or formulations of Алмол?

A: Regulatory data shows that the combination of Algeldrate and Magnesium Hydroxide is manufactured in different dosage forms and strengths. While the input is an oral suspension, the medicine is also available in forms such as chewable tablets, with varying amounts of the active ingredients.


Q: Is it normal to feel a bit dizzy after taking Алмол?

A: Dizziness or drowsiness is listed as a potential symptom of hypermagnesemia (excess magnesium in the blood). Hypermagnesemia is a serious, although very rare, adverse reaction usually associated with high doses or impaired kidney function. The occurrence of this symptom requires professional review.


Q: Why is it recommended to store Алмол in its original container?

A: Official storage instructions require the container to be kept tightly closed and protected from freezing and excessive heat. Maintaining the product in its original, sealed container helps ensure its stability and maintains the intended quality and consistency of the liquid suspension.


Q: Are there specific symptoms that require a doctor's attention while on Алмол?

A: Regulatory information states that if symptoms worsen or if serious signs related to mineral toxicity are experienced, medical attention is required. These concerning signs can include confusion, severe bone pain, muscle weakness, or a rapid heart rate.


Q: Can people with a history of heart problems use Алмол?

A: Magnesium toxicity (hypermagnesemia), which is a serious, very rare adverse reaction, has been associated with effects on the heart. These effects include the potential for prolonged cardiac conduction time and heart block, as noted in official warnings. Caution is necessary for those with underlying cardiac conditions.


Q: Why does the packaging for Алмол have a black box warning?

A: Regulatory safety resources explicitly state that the combination product of aluminum hydroxide and magnesium hydroxide does not carry a Black Box Warning. A Black Box Warning is the strictest safety warning put on the labeling of a prescription drug by the FDA.


Q: What is the required monitoring or testing while on Алмол?

A: For patients who have compromised renal (kidney) function, official warnings indicate a heightened risk of hypermagnesemia. For this reason, clinical monitoring of serum magnesium levels is often recommended by health professionals.

How should Алмол be stored and disposed of?

How to Store and Dispose of Almol (Antacid Oral Suspension)

The storage and disposal of Almol (Aluminum Hydroxide and Magnesium Hydroxide oral suspension) must strictly follow official regulatory requirements to ensure product stability and safety.

Required Storage Conditions

The medicine must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). It is essential to protect the suspension from freezing and to store it away from excessive heat and moisture. The container must be kept tightly closed when not in use. As a mandatory safety measure, keep this medication out of the reach of children.

Official Disposal Rules

Unused or expired Almol must not be flushed down the toilet or poured into drains. Disposal should be carried out through an authorized medicine take-back program or by following local regulations for pharmaceutical waste, ensuring the product is inaccessible to children and pets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Алмол found in:

A-Z Index: